Rx (Prescription Medicine)
USD $ 389.00
Pivikto 150mg Tablet 是一种含有活性成分Rivaroxaban的药物。Rivaroxaban 是一种直接口服抗凝剂，通过抑制因子Xa（凝血级联反应中的关键环节）发挥作用。通过阻断因子Xa，Pivikto 有效降低凝血酶的生成，从而防止血栓的形成。这使其在预防非瓣膜性房颤患者的卒中和系统性血栓栓塞方面具有价值，同时也用于深静脉血栓（DVT）和肺栓塞（PE）的治疗及预防。它还用于预防接受髋关节或膝关节置换手术的患者发生DVT和PE。典型剂量为150mg每日一次，但可能因患者的具体情况和病史而有所调整。常见的不良反应可能包括出血、瘀血和胃肠道不适。必须严格按照医疗提供者的处方方案服用Pivikto。请将药片存放于室温，避免潮湿和热源。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Pack Quantity | |
| Strength |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Selpercatinib. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
